Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Stabilising The Biologics Supply Chain with Blockchain Alexandru Popa, Associate Director, Blockchain for Pharma Supply Chain at MSD The counterfeit business is booming. Counterfeit goods account for a whopping 27 billion EUR revenue lost annually in the Pharma industry due to count... 1 month ago | 39 mins Technologies and Platform Approach for Optimizing Downstream Purification... Ashish Saksule at Vertex Pharmaceuticals and Dr Alejandro Becerra at Thermo Fisher Scientific Full title: Technologies and Platform Approach for Optimizing Downstream Purification of Viral Vectors The promising success stories and advancement ... 3 weeks ago | 103 mins Trends and Future of Pharmaceutical Continuous Manufacturing Lawrence De Belder, at Pharmatech Associates, Inc. and Jan Vogeleer at Fette Compacting In this webinar, Lawrence De Belder will give an overview of the history, present, and expected future of continuous manufacturing for drug product, d... 1 month ago | 107 mins Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Dr. Jun Tian, Executive Director and Head of Upstream Process Development at WuXi Biologics Full title: Enabling Robust Biomanufacturing Through Systematic Understanding of Single-Use Systems and Stringent Process and Raw Material Controls S... 3 months ago | 43 mins Contamination Control Challenges Facing Cell Therapy Facilities Conor McMorrow at Takeda and Félix Montero-Julian at bioMérieux The presentation aims to provide an overview of challenges that can be faced with the knowledge that a one size fits all approach cannot be taken. Whi... 1 month ago | 101 mins Platform Technology To Speed Up CMC Process Dr H. Fai Poon, President, QuaCell Biotech Ltd The commercial success of monoclonal antibodies has made biologics become attractive to pharmaceutical companies . The approval pathway is often requi... 2 months ago | 32 mins Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture... Dr John Metcalfe, Senior Pharmaceutical Quality Assessor at FDA and Dr. Doug Botkin at Charles River Laboratories Full title: Burkholderia Cepacia Complex and Aqueous Non-Sterile Drug Manufacture: Updates from a CDER Microbiologist's Perspective During this webin... 1 month ago | 121 mins Challenges And Opportunities Of Continuous Bioprocessing And Risk Management Sethu Madhavan, Global Head of Insulin Operations at Biocon Biologics -Migrating Bioprocessing into the Existing Infrastructure with Carefully Controlled Risk Management Systems -Addressing The Opportunities and Challen... September 4, 2023 8:30am Advanced Technologies for Media and Process Optimization for Biologics Manu... Dr. Yaron Silberberg at Ajinomoto Genexine and Dr. Mehran Rafigh at Yokogawa Full title: Advanced Technologies for Media and Process Optimization for Biologics Manufacturing Cell culture media composition and upstream bioproce... October 17, 2023 5:30am Points to consider when defining a microbial control strategy... Friedrich von Wintzingerode, PhD, QC Lead iNeST Project (individualized Neoantigen Specific Therapy) Full title: Points to consider when defining a microbial control strategy for individualized ATMPs How are individualized ATMPs different from tradit... 2 months ago | 55 mins Load more
